Skip to main content
Premium Trial:

Request an Annual Quote

TEDCO Funds Ariadne Genomics With $75K for Pathway Simulation Software

NEW YORK, Nov. 8 (GenomeWeb News) - Maryland Technology Development Corporation has allocated $75,000 in early-stage funding for Ariadne Genomics to help it develop biological pathway-simulation software, Ariadne Genomics said today.

 

The funding comes through TEDCO's Maryland Technology Transfer Fund, the company said.

 

The PathwaySolver tool is designed to calculate concentrations of biochemical compounds for different times and conditions and simulate the dynamics of biological pathways, according to the company.

 

"Pathway simulation module will be integrated with our PathwayStudio and PathwayExpert products to expand their functionality and better suit the needs of researchers," Ilya Mazo, president of Ariadne Genomics, said in a statement.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.